MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 44 filers reported holding MIRATI THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,867,409 | +180.7% | 157,654 | +132.9% | 0.01% | +150.0% |
| Q2 2023 | $2,446,145 | -64.2% | 67,704 | -63.2% | 0.00% | -60.0% |
| Q1 2023 | $6,840,860 | +2.2% | 183,993 | +24.6% | 0.01% | 0.0% |
| Q4 2022 | $6,692,922 | +21.1% | 147,714 | +86.6% | 0.01% | +25.0% |
| Q3 2022 | $5,528,000 | -32.8% | 79,162 | -35.4% | 0.00% | -33.3% |
| Q2 2022 | $8,223,000 | +386.0% | 122,493 | +494.7% | 0.01% | +500.0% |
| Q1 2022 | $1,692,000 | -66.9% | 20,599 | -40.9% | 0.00% | -66.7% |
| Q4 2021 | $5,113,000 | +55.3% | 34,850 | +87.2% | 0.00% | +50.0% |
| Q3 2021 | $3,292,000 | -41.0% | 18,612 | -46.1% | 0.00% | -33.3% |
| Q2 2021 | $5,575,000 | +10.5% | 34,511 | +17.2% | 0.00% | 0.0% |
| Q1 2021 | $5,046,000 | -72.0% | 29,455 | -64.1% | 0.00% | -72.7% |
| Q4 2020 | $18,044,000 | +425.6% | 82,150 | +297.2% | 0.01% | +450.0% |
| Q3 2020 | $3,433,000 | -50.8% | 20,680 | -66.2% | 0.00% | -60.0% |
| Q2 2020 | $6,984,000 | +87.9% | 61,162 | +26.5% | 0.01% | +66.7% |
| Q1 2020 | $3,717,000 | -44.7% | 48,345 | -7.3% | 0.00% | -40.0% |
| Q4 2019 | $6,716,000 | +36.9% | 52,127 | -17.2% | 0.01% | +25.0% |
| Q3 2019 | $4,904,000 | -41.8% | 62,937 | -23.1% | 0.00% | -42.9% |
| Q2 2019 | $8,429,000 | +383.0% | 81,835 | +243.5% | 0.01% | +250.0% |
| Q1 2019 | $1,745,000 | -75.2% | 23,827 | -85.7% | 0.00% | -71.4% |
| Q4 2018 | $7,045,000 | +142.2% | 166,089 | +168.9% | 0.01% | +133.3% |
| Q3 2018 | $2,909,000 | +139.6% | 61,764 | +150.8% | 0.00% | +200.0% |
| Q2 2018 | $1,214,000 | +48.4% | 24,631 | -7.5% | 0.00% | 0.0% |
| Q1 2018 | $818,000 | +7.9% | 26,623 | -35.9% | 0.00% | 0.0% |
| Q4 2017 | $758,000 | – | 41,524 | +4152300.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 1 | -99.6% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 225 | +12.5% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 200 | +4.7% | 0.00% | – |
| Q3 2016 | $1,000 | -66.7% | 191 | -67.7% | 0.00% | – |
| Q2 2016 | $3,000 | -98.9% | 591 | -95.3% | 0.00% | – |
| Q1 2016 | $269,000 | +62.0% | 12,528 | +139.1% | 0.00% | – |
| Q4 2015 | $166,000 | -98.6% | 5,240 | -98.5% | 0.00% | -100.0% |
| Q3 2015 | $11,766,000 | +15381.6% | 341,821 | +14054.1% | 0.01% | – |
| Q2 2015 | $76,000 | +484.6% | 2,415 | +413.8% | 0.00% | – |
| Q1 2015 | $13,000 | -43.5% | 470 | -61.8% | 0.00% | – |
| Q4 2014 | $23,000 | +475.0% | 1,231 | +392.4% | 0.00% | – |
| Q3 2014 | $4,000 | +300.0% | 250 | +309.8% | 0.00% | – |
| Q2 2014 | $1,000 | 0.0% | 61 | +110.3% | 0.00% | – |
| Q1 2014 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |